Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSyncona Regulatory News (SYNC)

Share Price Information for Syncona (SYNC)

Share Price is delayed by 15 minutes
Get Live Data
95.80    0.40 (0.42%)
Bid:
95.80
Ask:
96.80
Spread: 1.00 (1.044%)
Market Cap: £582.65m
SYNC Live PriceLast checked at - London Stock Exchange

Intraday Syncona Share Chart

Director/PDMR Shareholding

27 Mar 2019 11:12

RNS Number : 1827U
Syncona Limited
27 March 2019
 

Syncona Limited

Notification of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs") and Connected Persons

 

27 March 2019

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Nicholas Moss

b)

Position / status

Senior Independent Director

c)

Initial notification / amendment

Initial Notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares

GG00B8P59C08

 

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

2.497

8,004

d)

Aggregated information

Aggregated volume

Price

 N/A

e)

Date of the transaction

22 March 2019

f)

Place of the transaction

London Stock Exchange

g)

Currency

GBP - British Pound

 

 

[ENDS]

 

Enquiries

Syncona Ltd

Annabel Clay

Tel: +44 (0) 20 7611 2031

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUBRARKKAOUAR
Date   Source Headline
12th Nov 20241:18 pmRNSAutolus reports Q3 2024 Financial Results
12th Nov 20247:00 amRNSTransaction in Own Shares
11th Nov 20247:00 amRNSAutolus receives US FDA approval
11th Nov 20247:00 amRNSTransaction in Own Shares
8th Nov 20247:00 amRNSTransaction in Own Shares
7th Nov 20247:00 amRNSTransaction in Own Shares
6th Nov 20247:00 amRNSTransaction in Own Shares
5th Nov 20247:00 amRNSTransaction in Own Shares
4th Nov 20247:00 amRNSTransaction in Own Shares
1st Nov 202411:57 amRNSTotal Voting Rights
1st Nov 20247:00 amRNSTransaction in Own Shares
31st Oct 20247:00 amRNSTransaction in Own Shares
30th Oct 20247:00 amRNSTransaction in Own Shares
29th Oct 20247:00 amRNSTransaction in Own Shares
28th Oct 20247:00 amRNSTransaction in Own Shares
25th Oct 20247:00 amRNSTransaction in Own Shares
24th Oct 20247:00 amRNSTransaction in Own Shares
23rd Oct 20247:05 amRNSSpur presents positive data from Phase I/II trial
23rd Oct 20247:00 amRNSTransaction in Own Shares
22nd Oct 20247:00 amRNSTransaction in Own Shares
21st Oct 20247:00 amRNSTransaction in Own Shares
18th Oct 20247:00 amRNSNotice of Results
18th Oct 20247:00 amRNSTransaction in Own Shares
17th Oct 20247:00 amRNSTransaction in Own Shares
16th Oct 20247:00 amRNSTransaction in Own Shares
15th Oct 20243:05 pmRNSBeacon announces positive data from Phase II trial
15th Oct 20247:00 amRNSTransaction in Own Shares
14th Oct 20247:00 amRNSTransaction in Own Shares
11th Oct 20247:00 amRNSTransaction in Own Shares
10th Oct 20247:00 amRNSTransaction in Own Shares
9th Oct 20247:00 amRNSPurespring Therapeutics Series B financing
9th Oct 20247:00 amRNSTransaction in Own Shares
8th Oct 20247:00 amRNSTransaction in Own Shares
7th Oct 20247:00 amRNSTransaction in Own Shares
4th Oct 20247:00 amRNSTransaction in Own Shares
3rd Oct 20247:00 amRNSResolution Series B and new Chair appointment
3rd Oct 20247:00 amRNSTransaction in Own Shares
2nd Oct 20247:00 amRNSTransaction in Own Shares
1st Oct 20242:17 pmRNSTotal Voting Rights
1st Oct 20247:00 amRNSTransaction in Own Shares
30th Sep 20247:00 amRNSTransaction in Own Shares
26th Sep 20247:00 amRNSTransaction in Own Shares
25th Sep 20247:00 amRNSTransaction in Own Shares
24th Sep 20247:00 amRNSTransaction in Own Shares
23rd Sep 20247:00 amRNSTransaction in Own Shares
20th Sep 20247:00 amRNSDirectorate Change
20th Sep 20247:00 amRNSTransaction in Own Shares
19th Sep 20243:00 pmRNSBeacon presents clinical data update
19th Sep 202412:03 pmRNSAchilles announces strategic update
19th Sep 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.